הרופאים המומחים שלנו

• ​מנהל יחידת קרינה במערך האונקולוגי
• חבר בועדת בחינות שלב א' ושלב ב'
• חבר בועדת ציוד לרדיותרפיה,  מרכז קופת חולים

1. ​MD 1983, Tomsk State Medical University, USSR
2. PhD 1990, Cancer Research Institute, Siberian Branch of the Academy of Medical Sciences, Tomsk, USSR

​מרצה בכיר באוניברסיטת בן־גוריון

1. ​Israeli Medical Association
2. Israeli Society for Clinical Oncology and Radiotherapy     
3. European Society for Medical Oncology     
4. European Society for Therapeutic Radiology and Oncology     
5. American Society for Radiation Oncology

1. ​K.Lavrenkov, M.Partridge, G.Cook and M.Brada. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother. Oncol. 2005; 77: 1-4    IF – 4.34
2. R.Mendes, K.Lavrenkov, J.L.Bedford, A.Henrys, S.Ashley and M. Brada. Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT. Radiother. Oncol. 2006; 78: 322-325   IF – 4.34
3. K.Lavrenkov, J.A.Christian, M.Partridge, E.Niotsikou, G.Cook, M.Parker, J.L.Bedford and M.Brada. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother. Oncol. 2007; 83: 156-162     IF – 4.34
4. K.Lavrenkov, S.Singh, J.A.Christian, M.Partridge, E.Niotsikou, G.Cook, J.L.Bedford and M.Brada. Effective avoidance of a functional SPECT-perfused lung using IMRT for non-small cell lung cancer: an update of a planning study. Radiother. Oncol. 2009; 91: 349-52    IF – 4.34